PDS5A and Alzheimer disease: Tocotrienol-rich fraction (TRF) supplementation was able to reduce fibrillar Aβ deposition in the hippocampus of an AD mouse model, and PDS5A was among the top 20 upregulated genes after six months of TRF supplementation [105].